CANNABINOID RECEPTOR MODULATORS
Compounds of formula (I) are modulators of cannabinoid receptor CB1, useful inter alia for treatment of obesity: Formula (I). Wherein:X is a bond, or a divalent radical selected from -C(R10)(R11)-*, -C(R10)(R11)-O-*, -C(R10)(R11)CH2-*, -C(R10)(R11)CH2-O-*, -CH2C(R10)(R11)-*, -CH2C(R10)(R11) -O-*. an...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.06.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds of formula (I) are modulators of cannabinoid receptor CB1, useful inter alia for treatment of obesity: Formula (I). Wherein:X is a bond, or a divalent radical selected from -C(R10)(R11)-*, -C(R10)(R11)-O-*, -C(R10)(R11)CH2-*, -C(R10)(R11)CH2-O-*, -CH2C(R10)(R11)-*, -CH2C(R10)(R11) -O-*. and -CH2-O-C(R10)(R11)-*, wherein the bond indicated by an asterisk is attached to the pyrazole ring; Z is a carboxyl isostere radical selected from the group specified; R3 is hydrogen, (C1-C)aIkyI or (C1C3)fluoroalkyl; R4 is a radical of formula -(AIk1)P-(Q1)r (L)s -Q2 wherein p, r, s, AIk1, L, Q1 and Q2 are as specified; or R3 and R4 taken together with the nitrogen to which they are attached form a cyclic amino ring of 4 to 7 ring atoms which is optionally substituted by a radical of formula -(L)s-Q2 wherein s, L and Q2 are as defined above, or by an optional substituent selected from hydroxy, methoxy, -NH2-, or mono- or di-(C1C3)alkylamino; R5, R6, R7 and R8 are each independently selected from hydrogen -F, -Cl, -Br, -CN, (C1-C3)alkyl, (C1C3)fluoroalkyl, cyclopropyl, and -OR9; R10 is hydrogen, (C1C3)alkyl, hydroxyl or NH2, and R11 is hydrogen or (C1-C3)alkyl; or R10 and R11 taken together with the carbon atom to which they are attached form a (C3-C5)cycloalkyl ring. |
---|---|
AbstractList | Compounds of formula (I) are modulators of cannabinoid receptor CB1, useful inter alia for treatment of obesity: Formula (I). Wherein:X is a bond, or a divalent radical selected from -C(R10)(R11)-*, -C(R10)(R11)-O-*, -C(R10)(R11)CH2-*, -C(R10)(R11)CH2-O-*, -CH2C(R10)(R11)-*, -CH2C(R10)(R11) -O-*. and -CH2-O-C(R10)(R11)-*, wherein the bond indicated by an asterisk is attached to the pyrazole ring; Z is a carboxyl isostere radical selected from the group specified; R3 is hydrogen, (C1-C)aIkyI or (C1C3)fluoroalkyl; R4 is a radical of formula -(AIk1)P-(Q1)r (L)s -Q2 wherein p, r, s, AIk1, L, Q1 and Q2 are as specified; or R3 and R4 taken together with the nitrogen to which they are attached form a cyclic amino ring of 4 to 7 ring atoms which is optionally substituted by a radical of formula -(L)s-Q2 wherein s, L and Q2 are as defined above, or by an optional substituent selected from hydroxy, methoxy, -NH2-, or mono- or di-(C1C3)alkylamino; R5, R6, R7 and R8 are each independently selected from hydrogen -F, -Cl, -Br, -CN, (C1-C3)alkyl, (C1C3)fluoroalkyl, cyclopropyl, and -OR9; R10 is hydrogen, (C1C3)alkyl, hydroxyl or NH2, and R11 is hydrogen or (C1-C3)alkyl; or R10 and R11 taken together with the carbon atom to which they are attached form a (C3-C5)cycloalkyl ring. |
Author | BJURLING, EMELIE MURRAY, ANTHONY HOEGBERG, THOMAS RECEVEUR, JEAN MARIE LINGET, JEAN-MICHEL ALMHOLT, DORTHE NIELSEN, PETER AADAL NOERREGAARD, PIA KARINA |
Author_xml | – fullname: NIELSEN, PETER AADAL – fullname: LINGET, JEAN-MICHEL – fullname: BJURLING, EMELIE – fullname: HOEGBERG, THOMAS – fullname: ALMHOLT, DORTHE – fullname: RECEVEUR, JEAN MARIE – fullname: MURRAY, ANTHONY – fullname: NOERREGAARD, PIA KARINA |
BookMark | eNrjYmDJy89L5WSQd3b083N08vTz93RRCHJ1dg0I8Q9S8PV3CfVxBLKCeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjkbmBhbmBmaOhMRFKAHY5Iwo |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | MODULATEURS DU RECEPTEUR DE CANNABINOIDES |
ExternalDocumentID | CA2708706A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2708706A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:53:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2708706A13 |
Notes | Application Number: CA20082708706 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090618&DB=EPODOC&CC=CA&NR=2708706A1 |
ParticipantIDs | epo_espacenet_CA2708706A1 |
PublicationCentury | 2000 |
PublicationDate | 20090618 |
PublicationDateYYYYMMDD | 2009-06-18 |
PublicationDate_xml | – month: 06 year: 2009 text: 20090618 day: 18 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
RelatedCompanies | 7TM PHARMA A/S |
RelatedCompanies_xml | – name: 7TM PHARMA A/S |
Score | 2.7441275 |
Snippet | Compounds of formula (I) are modulators of cannabinoid receptor CB1, useful inter alia for treatment of obesity: Formula (I). Wherein:X is a bond, or a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CANNABINOID RECEPTOR MODULATORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090618&DB=EPODOC&locale=&CC=CA&NR=2708706A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbE-c5DcFmPeOQTZbBJaMQ9iK72V3U2EXmqxEf--k9hUL3obdmH2AbPfvBfgVhOurIQwiWVUFkGE1gi3PYdIj0tLmKVeysbfkaT2aGo-zqxZDxZdLUzbJ_SzbY6IEiVR3uv2vV79OLHCNrdyfScWOPT2EE_8UO2sYw_hyVXDwI_yLMyYypjPqJoWvu5oTUSPoqG002jRTZv96CVoilJWvxElPoTdHJkt6yPoVcsB7LPu47UB7CWbeDeSG9FbH8MNo2lKg3GajUOliFiUT7JCSbJw-kSRej4BJY4mbERwpfn2VHNGt3syTqGPxn51Borl6bZjCJ0bpWeaxqsodZdz1CKkZwnJtSEM_2Rz_s_cBRx8x0Fscu9eQr9-_6iuEE5rcd1exBdvv3X9 |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXWVzkYbkTkzYEYWCCgvILU9NawCya91MZi_PsOWKoXvU12k9lHMvvtN7MzC3ArUoPVlCqCKteqgAgtCqVm6gIzS6ZSpZIq1vo74kQLZsrjXJ0PYNnnwnR1Qj-74ohoUQztvenO6_WPE8vt3lZu7ugSm94e_MJy-Z4dmwhPBu86lpelbkp4Qixi80luSbrYRvRsJEp7OjLCjim9OG1Syvo3ovhHsJ-hslVzDIN6NYYR6T9eG8NBvI13o7g1vc0JTImdJLYTJmnocrlHvKxIcy5O3Vlko_R8CpzvFSQQcKTFblULYu_mJJ_BEMl-fQ6cakqaLlOplCtTUeRXWklGWeItgpkqZaU4gcmfai7-6ZvCKCjiaBGFydMlHH7HRDTh3riCYfP-UV8jtDb0ptuULxhZeOc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CANNABINOID+RECEPTOR+MODULATORS&rft.inventor=NIELSEN%2C+PETER+AADAL&rft.inventor=LINGET%2C+JEAN-MICHEL&rft.inventor=BJURLING%2C+EMELIE&rft.inventor=HOEGBERG%2C+THOMAS&rft.inventor=ALMHOLT%2C+DORTHE&rft.inventor=RECEVEUR%2C+JEAN+MARIE&rft.inventor=MURRAY%2C+ANTHONY&rft.inventor=NOERREGAARD%2C+PIA+KARINA&rft.date=2009-06-18&rft.externalDBID=A1&rft.externalDocID=CA2708706A1 |